Current stock research snapshot · 7/8/26 49 days old

PODDInsulet

WATCH

Investment conviction●●○○○2 of 5 · current snapshot

Research target$256.70Current stock price target

Investment thesis statusINTACTLast reviewed 7/8/26

Market cap$11.39BSnapshot value · 7/8/26

Research history

What changed

Aug 26, 2026

Target
$256.30 → $256.70

Current investment thesis

Continuous insulin delivery: Omnipod automated insulin delivery integrating with CGM. Razor-blade model — Pod recurring revenue per patient.

Current stock catalysts

Automated insulin delivery adoption; CGM integration driving Pod demand; Type 2 diabetes expansion; pediatric adoption.

Current investment risks

Competitive pressure from Medtronic/Tandem; reimbursement concentration; GLP-1 reducing insulin-dependent diabetes prevalence long-term.

Stock social sentiment

Neutral — No investor-style discussion found. [X search Aug 2026]

Snapshot · 7/8/26

Institutional positioning

🟢 Confirmed · ins+$0.9M(2buy👥)→0.1M · 13F 17+/8-×0.5 · short↑0.33 · 🔗align

Snapshot · 7/8/26